PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Update

PURE Bioscience, Inc. (OTCMKTS:PURE) saw a significant growth in short interest in March. As of March 15th, there was short interest totalling 900 shares, a growth of 50.0% from the February 28th total of 600 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 106,200 shares, the days-to-cover ratio is currently 0.0 days.

PURE Bioscience Stock Up 4.2 %

Shares of PURE traded up $0.00 during mid-day trading on Monday, reaching $0.09. The company’s stock had a trading volume of 95,672 shares, compared to its average volume of 65,329. PURE Bioscience has a 1 year low of $0.05 and a 1 year high of $0.16. The company has a market cap of $10.30 million, a price-to-earnings ratio of -2.30 and a beta of 0.35. The business has a fifty day moving average of $0.07 and a 200 day moving average of $0.08.

PURE Bioscience (OTCMKTS:PURE) last announced its quarterly earnings data on Monday, March 17th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.39 million for the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.